Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

about

Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration.Trabectedin combined with liposomal doxorubicin in women with relapsed ovarian cancer.Determination of the phosphorylated metabolites of gemcitabine and of difluorodeoxyuridine by LCMSMS.

P2860

Q33384998-AB5CDBBC-4648-4011-A5C9-99E9773D6B42 Q37765581-855E207B-FDDF-4741-8822-DB7CE2839765 Q39434633-9BB5694C-6E04-4F7B-BE0B-7DA482135BD2

P2860

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

Item

http://www.wikidata.org/entity/Q36407477

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

@ast

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

@en

type

Item

label

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

@ast

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

@en

prefLabel

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

@ast

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

@en

P1476

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma

@en

P2093

M Faruk Kose

http://www.w3.org/2001/XMLSchema#string

M Mutlu Meydanli

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.

Is combination chemotherapy superior to single-agent chemotherapy in second-line treatment?

Remaining controversies in the upfront management of advanced ovarian cancer.

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.

Treatment goals in ovarian cancer.

Gemcitabine and carboplatin in second-line ovarian cancer.

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.

P304

437-443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.6.3.437

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

G Tulunay

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16503860

http://www.w3.org/2001/XMLSchema#string

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

about

P2860

P2860

Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698